Health Talk | To combat dengue menace, a promising vaccine candidate enters phase three trials in India

Health Talk | To combat dengue menace, a promising vaccine candidate enters phase three trials in India

Earlier this month, there were reports that the third phase of clinical trials of a dengue vaccine candidate will soon start across the country. PREMIUM (Representational Image) According to the company, the clinical studies showed the vaccine to be safe and well tolerated (AFP) One of the Indian Council of Medical Research (ICMR) research institutes, …

Read more

Takeda, Biological E tie up for dengue vaccine

Takeda, Biological E tie up for dengue vaccine

Takeda, a global biopharmaceutical company and Biological E. Limited (BE) on Tuesday announced a strategic partnership to accelerate access to Qdenga (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003), multi-dose vials (MDVs). A press release from Takeda said these doses will ultimately be made available for procurement by governments in endemic countries by 2030 at the latest …

Read more